Previous 10 | Next 10 |
2023-03-17 08:22:48 ET Enzo Biochem ( NYSE: ENZ ) +73% . PaxMedica ( PXMD ) +27% . FedEx ( FDX ) +11% . BigBear.ai Holdings ( BBAI ) +11% . Riot Blockchain ( RIOT ) +11% . Corbus Pharmaceuticals Holdings ( CRBP ) +10% ...
2023-03-16 13:08:25 ET Gainers: Genelux ( GNLX ) +49% . PureCycle Technologies ( PCT ) +46% . Baudax Bio ( BXRX ) +35% . Lipella Pharmaceuticals ( LIPO ) +32% . Corbus Pharmaceuticals Holdings ( CRBP ) +27% . EverCommer...
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update PR Newswire Company expands precision oncology pipeline with licensing of CRB-701, clinical-stage Nectin-4 antibody drug conjugate (ADC) from CSPC Pharmaceutical G...
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA PR Newswire NORWOOD, Mass. , March 6, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology compan...
Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference PR Newswire NORWOOD, Mass. , March 2, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, ...
Summary Jiangsu Hengrui Pharma out-licensed US rights for a novel small-molecule EZH2 inhibitor in a $706 million agreement with Connecticut's Treeline Biosciences. A CSPC Pharma subsidiary out-licensed ex-China rights for a Nectin-4 antibody drug conjugate to Boston’s Corbus Pha...
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR Newswire CRB-701 (SYS6002) is designed for improved therapeutic index and to act on a broad range of Nectin-4 expressing tumors ...
3 Tips for Profiting With Penny Stocks in December 2022 Penny stocks, while potentially lucrative, can be a difficult investment to navigate. Making money with penny stocks requires an in-depth knowledge of the stock market and a commitment to research and due diligence. While there are no gu...
Corbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting PR Newswire CRB-601 is a potent and selective anti -αvβ8 integrin monoclonal antibody designed to block the activation of l...
Corbus Pharmaceuticals press release ( NASDAQ: CRBP ): Q3 GAAP EPS of -$0.07 misses by $0.01 . Cash and investments on hand of $67 million funds operations through the second quarter of 2024. Latest pre-clinical data for CRB-601 monotherapy and in combination with ...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...